單分子即時定序市場規模、佔有率和成長分析：按服務類型、工作流程、應用、最終用戶和地區分類－2026-2033年產業預測

2024 年全球單分子即時 (SMRT)定序市場價值為 32 億美元，預計到 2025 年將成長至 35.7 億美元，到 2033 年將成長至 86.6 億美元，預測期（2026-2033 年）複合年成長率為 11.7%。

全球單分子即時（SMRT）定序市場的主要驅動力在於其長讀長、高保真讀段能夠解析短讀長平台無法組裝的複雜基因組區域。 SMRT技術能夠精確檢測、定位並直接識別鹼基修飾，使其成為精準醫療、農業基因組學和微生物生態學等領域應用的關鍵技術。高保真讀段帶來的準確性和通量提升，拓展了此技術的效用，使其能夠常規應用於全面的基因組組裝和臨床診斷。隨著成本的降低和樣本製備的簡化，SMRT技術的應用範圍正從特定領域擴展到更廣泛的應用。人工智慧（AI）的運用進一步提升了準確性和處理通量，最佳化了工作流程，並減少了錯誤，從而推動了SMRT定序領域的成長，並創造了新的收入來源。

全球單分子即時（SMRT）定序市場的成長要素

全球單分子即時定定序(SMRT) 市場的主要促進因素之一是對個人化醫療和基因組研究日益成長的需求。隨著醫療保健產業轉向基於個人基因資訊的個人化治療模式轉變，對先進定序技術的需求也隨之激增。 SMRT定序能夠實現長讀長和高精度分析複雜的基因組區域，使研究人員和臨床醫生能夠揭示關鍵的基因變異和突變。這種能力加深了我們對各種疾病的理解，加速了標靶治療的開發，從而推動了專注於基因組學和生物技術的學術界和產業界的發展。

全球單分子即時（SMRT）定序市場面臨的限制因素

全球單分子即時（SMRT）定序市場的主要限制因素之一是先進定序技術的高成本。 SMRT定序設備的部署和維護需要大量的資金投入，這對於預算有限的小規模研究機構和實驗室而言可能構成准入門檻。此外，該技術的複雜性要求進行專門的培訓和操作，進一步增加了營運成本。這些因素可能會阻礙學術界、醫療保健和生物技術領域潛在用戶的廣泛採用，從而限制了整體市場成長，儘管技術不斷進步且應用領域廣泛。

全球單分子即時（SMRT）定序市場趨勢

全球單分子即時（SMRT）定序市場正呈現出向臨床研究應用顯著發展的趨勢，其應用範圍已從傳統的基因組學研究擴展到轉化研究和臨床試驗等更複雜的領域。這項轉變主要得益於SMRT定序能夠精準分析長讀長序列、表觀遺傳修飾和複雜的結構變異。因此，醫療機構正擴大利用這些技術進行生物標記發現、罕見疾病診斷以及藥物基因體學學研究。臨床檢查室和研究機構之間日益成長的合作需求，推動了對檢驗的方法和標準化方案的需求，也進一步凸顯了市場對承包平台和全面支援服務的需求，以促進臨床部署和實施。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

關鍵市場分析

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場魅力指數
• PESTLE分析
• 監理情勢

全球單分子即時定序市場規模：依服務類型分類

• 裝置
• 耗材和試劑
• 軟體和生物資訊解決方案
• 定序服務

全球單分子即時定序序市場規模：依工作流程分類

• 樣品製備及樣品製備
• 定序
• 數據處理與分析

全球單分子即時定序序市場規模：按應用領域分類

• 全基因測序
• 標靶定序
• RNA定序和轉錄組學
• 表觀遺傳學和甲基化分析
• 總體基因體學和微生物定序
• 結構突變檢測
• 從頭基因組組裝
• HLA型檢測與免疫基因體學
• 罕見疾病和遺傳性疾病的研究
• 腫瘤學研究和癌症基因組學
• 農業和動物基因組學
• 藥物發現與開發
• 其他

全球單分子即時定序市場規模：依最終用戶分類

• 學術研究機構
• 製藥和生物技術公司
• 醫院和臨床檢查室
• 受託研究機構（CRO）
• 政府與公共衛生實驗室
• 其他

全球單分子即時定序市場規模：按地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太國家
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲國家

競爭資訊

• 前五大公司對比
• 主要公司2025年的市場定位
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市場占有率分析，2025 年
• 主要公司的完整公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 銷售收入年比比較（2023-2025 年）

主要公司簡介

• Pacific Biosciences
• Illumina
• Oxford Nanopore Technologies
• Thermo Fisher Scientific
• BGI Genomics
• QIAGEN
• Roche
• Agilent Technologies
• Revvity
• Standard BioTools
• Takara Bio
• Azenta Life Sciences
• GeneDx
• Novogene
• Macrogen
• GenScript Biotech
• Psomagen
• CD Genomics
• SeqMatic
• Genewiz

結論與建議

Global Single-Molecule Real-Time (Smrt) Sequencing Market size was valued at USD 3.2 Billion in 2024 and is poised to grow from USD 3.57 Billion in 2025 to USD 8.66 Billion by 2033, growing at a CAGR of 11.7% during the forecast period (2026-2033).

The global Single-Molecule Real-Time (SMRT) sequencing market is primarily driven by the unparalleled capability of long, high-fidelity reads to uncover complex genomic regions that short-read platforms fail to assemble. SMRT technology facilitates accurate structural variant detection, phasing, and direct identification of base modifications, making it essential for applications in precision medicine, agricultural genomics, and microbial ecology. The advances in accuracy and throughput due to high-fidelity reads have expanded the technology's utility, enabling comprehensive genome assemblies and routine use in clinical diagnostics. With decreasing costs and simplified sample preparation, adoption has moved beyond niche projects. Artificial intelligence further enhances accuracy and processing throughput, optimizing workflows and reducing errors, catalyzing growth and fostering new revenue streams in the SMRT sequencing landscape.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Single-Molecule Real-Time (Smrt) Sequencing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Single-Molecule Real-Time (Smrt) Sequencing Market Segments Analysis

Global single-molecule real-time (smrt) sequencing market is segmented by offering, workflow, application, end user and region. Based on offering, the market is segmented into Instruments, Consumables & Reagents, Software & Bioinformatics Solutions and Sequencing Services. Based on workflow, the market is segmented into Sample Preparation & Library Preparation, Sequencing and Data Processing & Analysis. Based on application, the market is segmented into Whole Genome Sequencing, Targeted Sequencing, RNA Sequencing & Transcriptomics, Epigenetics & Methylation Analysis, Metagenomics & Microbial Sequencing, Structural Variant Detection, De Novo Genome Assembly, HLA Typing & Immunogenomics, Rare Disease & Genetic Disorder Research, Oncology Research & Cancer Genomics, Agricultural & Animal Genomics, Drug Discovery & Development and Others. Based on end user, the market is segmented into Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Hospitals & Clinical Laboratories, Contract Research Organizations (CROs), Government & Public Health Laboratories and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Single-Molecule Real-Time (Smrt) Sequencing Market

One key market driver for the Global Single-Molecule Real-Time (SMRT) Sequencing Market is the increasing demand for personalized medicine and genomic research. As healthcare shifts towards more tailored treatments based on individual genetic information, the need for advanced sequencing technologies has surged. SMRT sequencing allows for long-read capabilities and higher accuracy in characterizing complex genomic regions, enabling researchers and clinicians to uncover critical genetic variations and mutations. This capability enhances the understanding of various diseases and accelerates the development of targeted therapies, thereby fostering growth in both academic and industrial sectors focused on genomics and biotechnology.

Restraints in the Global Single-Molecule Real-Time (Smrt) Sequencing Market

One of the primary market restraints for the Global Single-Molecule Real-Time (SMRT) Sequencing Market is the high cost associated with advanced sequencing technologies. The installation and maintenance of SMRT sequencing instruments require significant financial investment, which can be a barrier to entry for smaller research institutions and laboratories with limited budgets. Additionally, the complexity of the technology necessitates specialized training and expertise, further increasing operational costs. These factors may hinder widespread adoption among potential users in academia, healthcare, and biotechnology sectors, thereby limiting the overall growth of the market despite its technological advancements and potential applications.

Market Trends of the Global Single-Molecule Real-Time (Smrt) Sequencing Market

The Global Single-Molecule Real-Time (Smrt) Sequencing market is experiencing a significant trend towards expanded clinical research applications, moving beyond traditional genomic studies into more complex areas such as translational and clinical research. This shift is fueled by Smrt sequencing's capability to accurately resolve long reads, epigenetic modifications, and intricate structural variants. Consequently, healthcare institutions are increasingly utilizing these technologies for biomarker discovery, diagnosing rare diseases, and advancing pharmacogenomics. The burgeoning demand for collaboration between clinical laboratories and research institutions is driving the need for validated methods and standardized protocols, further highlighting the market's requirement for turnkey platforms and comprehensive support services to facilitate clinical adoption and implementation.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Single-molecule Real-time (SMRT) Sequencing Market Size by Offering & CAGR (2026-2033)

• Market Overview
• Instruments
• Consumables & Reagents
• Software & Bioinformatics Solutions
• Sequencing Services

Global Single-molecule Real-time (SMRT) Sequencing Market Size by Workflow & CAGR (2026-2033)

• Market Overview
• Sample Preparation & Library Preparation
• Sequencing
• Data Processing & Analysis

Global Single-molecule Real-time (SMRT) Sequencing Market Size by Application & CAGR (2026-2033)

• Market Overview
• Whole Genome Sequencing
• Targeted Sequencing
• RNA Sequencing & Transcriptomics
• Epigenetics & Methylation Analysis
• Metagenomics & Microbial Sequencing
• Structural Variant Detection
• De Novo Genome Assembly
• HLA Typing & Immunogenomics
• Rare Disease & Genetic Disorder Research
• Oncology Research & Cancer Genomics
• Agricultural & Animal Genomics
• Drug Discovery & Development
• Others

Global Single-molecule Real-time (SMRT) Sequencing Market Size by End User & CAGR (2026-2033)

• Market Overview
• Academic & Research Institutes
• Pharmaceutical & Biotechnology Companies
• Hospitals & Clinical Laboratories
• Contract Research Organizations (CROs)
• Government & Public Health Laboratories
• Others

Global Single-molecule Real-time (SMRT) Sequencing Market Size & CAGR (2026-2033)

• North America (Offering, Workflow, Application, End User)
  • US
  • Canada
• Europe (Offering, Workflow, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Offering, Workflow, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Offering, Workflow, Application, End User)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Offering, Workflow, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Pacific Biosciences
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Illumina
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Oxford Nanopore Technologies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BGI Genomics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QIAGEN
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Revvity
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Standard BioTools
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takara Bio
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Azenta Life Sciences
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GeneDx
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novogene
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Macrogen
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GenScript Biotech
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Psomagen
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CD Genomics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SeqMatic
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Genewiz
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations